- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 10th, 2004
Research and Markets has announced the addition of Nanobiotechnology: Opportunities and Technical Analysis to their offering.
Several industries are hindered by the limitations of current technologies. In medicine, clinical diagnostics are often costly and time-consuming. Additionally, most therapeutics lack specificity, and therefore are limited in efficacy and safety. In life science research, the drug discovery process continues to be slowed by existing imaging and screening techniques. Nanobiotechnology promises to provide novel tools and materials that address current technological limitations, and thereby holds great promise for significant advances in both medicine and life science research.
|Related News Press|
Stealth nanocapsules kill Chagas parasites in mouse models June 22nd, 2016
FEI Launches Helios G4 DualBeam Series for Materials Science: The Helios G4 DualBeam Series features new capabilities to enable scientists and engineers to answer the most demanding and challenging scientific questions June 27th, 2016